Abeona Therapeutics ABEO
NASDAQ ABEO
$2.60 +0.18 (+7.44%)
At close: Nov 16, 2026 · 4:00 PM EST

Abeona Therapeutics (ABEO) Depreciation and Depletion (2012 - 2023)

Updated

Abeona Therapeutics (ABEO) reported Depreciation and Depletion of $700,000 for Q1 2023, down 12.5% from $800,000 a year earlier.

Analysis

Abeona Therapeutics (ABEO) Depreciation and Depletion (2012 - 2023) Analysis & Trends

  • The Q1 2023 figure ranks as the lowest quarterly Depreciation and Depletion since Q4 2012.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Depletion (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn -
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn -
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn 192.00 Mn
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn 726.00 Mn
5 Novartis Ag 310.90 Bn 284.14 Bn - -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn -
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn -
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn 132.00 Mn
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn -
10 Abeona Therapeutics 149.28 Mn -492.16 Mn 7.78 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2023 700,000.00
Mar 31, 2022 800,000.00
Dec 31, 2012 29,000.00
API Access

Abeona Therapeutics Depreciation and Depletion API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-depletion&ticker=ABEO&period=max&api_key=YOUR_API_KEY